Following the mRNA unleashing in CD8+ T cells, T cells were reprogrammed to transiently express tumor-specific CAR or virus-specific TCR, which induced tumor regression comparable to therapeutic outcome of ACT [152]. The gene discussed is CD8A; the disease is neoplasm.